Selected publications (complete list here):

  1. Frohlich J, Miller M, Bird LM, Garces P, Purtell H, Hoener MC, Philpot BD, Sidorov MS, Tan WH, Hernandez MC, Rotenberg A, Jeste SS, Krishnan M, Khwaja O, Hipp JF (2019). Electrophysiological phenotype in Angelman syndrome differs between genotypes. Biological Psychiatry 85(9): 752-759. [pdf]
  2. den Bakker H*, Sidorov MS*, Lee DJ, Fan Z, Bird LM, Chu CJ, and Philpot BD (2018). Abnormal coherence and sleep composition in children with Angelman syndrome: a retrospective EEG study. Molecular Autism 9:32. [pdf]
  3. Sidorov MS, Judson MC, Kim H, Rougie M, Ferrer AI, Nikolova VD, Riddick NV, Moy SS, and Philpot BD (2018). Enhanced operant extinction and prefrontal excitability in a mouse model of Angelman syndrome. Journal of Neuroscience 38(11): 2671-2682. [pdf]
  4. Sidorov MS, Deck GM, Dolatshahi M, Bird LM, Thibert RL, Chu CJ, and Philpot BD (2017). Delta rhythmicity is a reliable EEG biomarker in Angelman syndrome: a parallel mouse and human analysis. Journal of Neurodevelopmental Disorders 9:17. [pdf] [erratum]
  5. Judson MC*, Wallace ML*, Sidorov MS, Burette AC, Gu B, Van Woerden GM, King IF, Han JE, Zylka MJ, Elgersma Y, Weinberg RJ, and Philpot BD (2016). GABAergic neuron-specific loss of Ube3a causes Angelman syndrome-like EEG abnormalities and enhances seizure susceptibility. Neuron 90: 56-69. [pdf]
  6. Sidorov MS, Kaplan ES, Osterweil EK, Lindemann L, and Bear MF (2015). Metabotropic glutamate receptor signaling is required for NMDA receptor-dependent ocular dominance plasticity and LTD in visual cortex. PNAS 112(41): 12852-12857. [pdf]
  7. Sidorov MS, Krueger DD, Taylor M, Gisin E, Osterweil EK, and Bear MF (2014). Extinction of an instrumental response: a cognitive behavioral assay in Fmr1 knockout mice. Genes Brain and Behavior 13(5): 451-458. [pdf]
  8. Sidorov MS, Auerbach BD, and Bear MF (2013). FMRP and synaptic plasticity. Molecular Brain 6:15. [pdf]
  9. Michalon A*, Sidorov M*, Ballard TA, Ozmen L, Spooren W, Wettstein J, Jaeschke G, Bear MF, and Lindemann L (2012). Chronic pharmacological mGlu5 inhibition corrects Fragile X in adult mice. Neuron 74(1): 49-56. [pdf]